Finance

Lists
Why is BALAXI down 2,19%?
Dive Deeper
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
22,28 ₹
-2,19%
(-0,50) 1D
1 հոկ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
23,19 ₹
High
23,19 ₹
Low
22,20 ₹
Mkt. cap
1,21 մլրդ
Avg. vol.
50,52 հզր
Volume
20,51 հզր
P/E ratio
50,39
52-wk high
45,34 ₹
52-wk low
15,20 ₹
EPS
0,44 ₹
No. of employees
500
Open
23,19 ₹
High
23,19 ₹
Low
22,20 ₹
Mkt. cap
1,21 մլրդ
Avg. vol.
50,52 հզր
Volume
20,51 հզր
P/E ratio
50,39
52-wk high
45,34 ₹
52-wk low
15,20 ₹
EPS
0,44 ₹
No. of employees
500
News stories
From web sources and news partners
About Balaxi Pharmaceuticals Ltd
CEO-
Employees500
Founded1942
Headquarters-
SectorHealth care provider
Websitebalaxipharma.in
Last report
05 օգս, 2026 թ.
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
806,82 մլն / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
561,75 մլն
725,42 մլն
707,14 մլն
806,82 մլն
Cost of goods sold
290,29 մլն
417,35 մլն
414,90 մլն
431,74 մլն
Cost of revenue
290,29 մլն
417,35 մլն
414,90 մլն
431,74 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
259,77 մլն
277,18 մլն
291,02 մլն
328,46 մլն
Operating expense
264,62 մլն
282,77 մլն
297,48 մլն
336,94 մլն
Total operating expenses
554,91 մլն
700,12 մլն
712,38 մլն
768,68 մլն
Operating income
6,84 մլն
25,30 մլն
-5,25 մլն
38,14 մլն
Other non operating income
15,85 մլն
957,00 հզր
18,30 մլն
-9,92 մլն
EBT including unusual items
13,77 մլն
16,10 մլն
14,03 մլն
20,89 մլն
EBT excluding unusual items
13,77 մլն
16,10 մլն
12,99 մլն
20,89 մլն
Income tax expense
11,68 մլն
13,05 մլն
7,90 մլն
7,92 մլն
Effective tax rate
84,82%
81,05%
56,31%
37,90%
Other operating expenses
-
-
-
-
Net income
2,09 մլն
3,05 մլն
6,13 մլն
12,97 մլն
Net profit margin
0,37%
0,42%
0,87%
1,61%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-8,92 մլն
-10,16 մլն
-9,90 մլն
-7,33 մլն
Net interest expenses
-8,92 մլն
-10,16 մլն
-9,90 մլն
-7,33 մլն
Depreciation and amortization charges
4,84 մլն
5,60 մլն
6,46 մլն
8,48 մլն
EBITDA
11,58 մլն
29,57 մլն
-328,75 հզր
43,06 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps